|
HS Code |
505509 |
| Cas Number | 84494-72-4 |
| Molecular Formula | C24H36O2 |
| Molecular Weight | 356.54 g/mol |
| Iupac Name | ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate |
| Boiling Point | Estimated above 200°C (decomposes) |
| Appearance | Colorless to pale yellow liquid |
| Solubility | Insoluble in water, soluble in organic solvents |
| Density | Approx. 0.93 g/cm³ (at 25°C) |
| Synonyms | DHA ethyl ester, Docosahexaenoic acid ethyl ester |
| Storage Temperature | Store at -20°C, protected from light and air |
As an accredited Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 100 mg Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate is packaged in a sealed amber glass vial to ensure stability. |
| Shipping | Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate is shipped in tightly sealed containers under cool, dry conditions, protected from light and moisture. Handling requires chemical-resistant gloves and eye protection. The shipment complies with all regulatory guidelines for non-hazardous chemicals and is typically transported via ground or air, ensuring product stability and integrity. |
| Storage | Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate should be stored in a cool, dry, and well-ventilated area, protected from light and moisture. Store tightly sealed in an inert atmosphere, such as under nitrogen or argon, to prevent oxidation. Recommended storage temperature is -20°C or lower. Avoid exposure to air and strong oxidizing agents to maintain stability and purity. |
|
Purity 99%: Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate with a purity of 99% is used in pharmaceutical synthesis, where it ensures high yield and minimal impurities in active pharmaceutical ingredients. Molecular Weight 356.55 g/mol: Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate with a molecular weight of 356.55 g/mol is used in lipid research, where it enables precise formulation and accurate dosing in experimental protocols. Stability Temperature up to 4°C: Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate stable up to 4°C is used in clinical sample storage, where it preserves compound integrity during refrigerated handling. Viscosity 20 cP: Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate with a viscosity of 20 cP is used in emulsion preparation for nutraceuticals, where it allows optimal mixing and stable dispersion. Melting Point -44°C: Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate with a melting point of -44°C is used in cold-chain logistics, where it maintains liquid form at low temperatures for efficient cold processing. Particle Size <10 µm: Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate with a particle size under 10 µm is used in microencapsulation, where it enhances bioavailability and uniform distribution in delivery systems. |
Competitive Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Factory floors hum with more than machines—they pulse with decades of knowhow, real-world engineering, and a constant drive to refine raw materials. In that spirit, our Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate—or ethyl ester of docosahexaenoic acid, DHA-EE for short—stands out in both quality and purpose. We produce and purify it on-site, where full traceability through every stage of synthesis ensures consistent integrity tank by tank, drum by drum. This compound holds high value for formulators searching for purity, reproducibility, and genuine performance without the distractions that come from inconsistent sourcing.
DHA forms a cornerstone of many formulations, especially in food enrichment, supplements, infant nutrition, and increasingly, specialty medical applications. Ethyl esters like this one meet the balance between functionality and handling: its structure resists common processing breakdowns, keeps the molecular configuration meant for bioavailability, and offers the flexibility demanded by today’s research and commercial teams.
While the basics might look similar from a distance—lots of long polyunsaturated chains abound in marine and algal sources—details separate top-grade DHA-EE from run-of-the-mill fish oils and less refined esters. Impurities tell tales. Left unchecked, non-cis isomers or leftover byproducts detract from consistent use and introduce variables that downstream product developers simply don’t want to confront. We have learned this through years solving production headaches for clients who brought challenges to our door after other suppliers fell short—not all manufacturers share the same priorities.
Some assume making ethyl DHA ester requires the same precautions as commodity fats, but this approach invites problems. Unsaturated fatty acids demand tight control at each transformation, from raw DHA extraction through the esterification step. We never ignore oxygen exclusion, temperature settings, or catalyst purity. Fatty acid chain oxidation triggers off-flavors, darkens color, and renders product unstable. In the lab, it’s just as easy to make a mess as it is to make something valuable. Our chemists have spent decades watching reactions, tweaking flows, and designing efficient purification systems. Every day we see the difference between efficient scale-up methods and shortcuts that only look good on paper. The end result proves itself—the downline acceptance rate stays high, and test results line up again and again.
Each drum of our Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate represents a well-defined molecular profile. Customers expect at least 90% purity; we regularly deliver 95% or better by modern GC and HPLC analysis, with all six double bonds firmly in the cis configuration. Our batches routinely surpass minimum thresholds for peroxide, anisidine, and heavy metal content.
Traceability is more than a paperwork exercise—it’s embedded throughout our operation. Batch numbers connect directly to production records, test data, and ingredient inputs. If a customer ever faces an analytical question, we can show the step-by-step path from raw input through finished ester, including any intervention or retesting along the way. This approach has served industrial blenders, nutraceutical developers, and R&D teams who face regulatory audits or need to resolve discrepancies quickly.
Nutritional and life sciences fields drive repeated requests for high-purity DHA-EE. It finds its way into softgel capsules, nutritional bars, infant formula additives, and investigational therapies. We have worked directly with organizations calibrating micronutrient blends for cognitive function, prenatal support, and therapeutic interventions for neurodegenerative disorders. In each of those projects, stability and authenticity matter as much as headline purity.
We often hear from production specialists dealing with formulation drift during shelf life or packaging runs. High-grade DHA-EE helps avoid rancidity and breakdown under common storage temperatures. Its lower tendency to polymerize or form secondary reaction products means extended shelf-life and reliable performance for finished goods. Over the years, our technical teams have pulled samples and analyzed them months after initial delivery, confirming that meticulous processing pays dividends in reduced customer complaints and improved end-use yields.
Those outside the production side of chemistry sometimes see omega-3 ingredient listings and assume all products with “DHA” in the title are interchangeable. Our experience says otherwise. Fish or algal oils vary wildly in composition. The ethyl ester form, on the other hand, allows formulators to reach higher DHA concentrations and avoid undesirable contaminants commonly present in raw or semi-refined oils.
We often meet researchers testing both triglyceride and ethyl ester forms in parallel. Triglycerides mimic the lipid profile found in whole foods. Ethyl esters, due to their modified structure, behave differently during encapsulation, controlled release, and analytical testing. Our DHA-EE resists oxidation better than many triglycerides, maintaining clarity and characteristic odor through extended storage. For large-scale nutritional fortification, where cost, purity, and shelf stability intersect, ethyl esters often land as the preferred format. We only reached this understanding through years of customer collaborations and troubleshooting performance issues with alternative materials.
Refinement techniques make a world of difference. Starting with precursor molecules that have spent months or years at sea introduces risks for contamination, hydrolysis, pesticide residues, and off-odors. Many suppliers purchase intermediate concentrates, blend or slightly refine them, and miss nuances that matter to customers seeking consistent results. Our vertical integration, starting with carefully sourced DHA-rich oils and built upon proprietary purification stages, gives more certainty batch to batch.
Production volumes have grown steadily alongside steady investments in analytics and controls. We run modern chromatographs, calculate isomer ratios, and log every deviation, no matter how small. Each specification target—double bond retention, low peroxide value, color index, and reduction of environmental contaminants—feeds straight into our release process. As refinements have advanced, so has our ability to produce DHA-EE with dehydrated molecular arrangements that maximize bioactive cis isomers.
Over many production runs, we’ve discovered trace contaminants, such as trans isomers and environmental residues, can derail entire formulation projects. Addressing these issues starts at the level of raw material screening. Analytical transparency earns us the trust of clients who operate under strict regulatory environments—infant formula, clinical nutrition, and FDA-reviewed therapies. Ethyl ester forms open doors to higher potency ingredients, but only if produced under unwavering standards and verified before release.
A recurring hurdle in DHA-EE production comes from safe handling and byproduct control. Cleaning and maintaining reactors, screening catalysts for trace metals, and confirming the absence of unknown peaks in chromatograms takes constant attention. Minor neglect in equipment sterilization or process gas purity leaves a mark in impurity profiles, which show up as early rancidity, odor, or reduced absorption in downstream applications. We address these risks by putting boots on the ground in our reactors and QC labs, not just relying on remote monitoring. Employees receive direct feedback from technical leads, and decisions on reruns or adjustments happen quickly with full data review.
Scaling up from lab scale to plant scale remains another pain point for many newer firms. Temperature gradients, mixing inefficiencies, or delays between core processes all raise the opportunity for polymerization or side reactions. Market pressure often tempts new entrants to skip stability tests or compress refinement routines in the hunt for better margins. Our facility and process layout grew organically from smaller, manual beginnings. Each expansion meant adapting batch sizes to retain oversight: larger tanks followed proven pilot protocols, not short-term production boosts that could create scale-induced defects.
Certification and compliance matter too. Over the last decade, we have answered more regulatory inquiries than press releases. Repeated audits from food safety and pharmacological agencies test not just paperwork but sampling consistency and correct responses to potential deviations. DHA-EE meets more than chemical purity; the absence of dioxins, PCBs, and trace heavy metals often determines eligibility for particular markets. Internal standards usually exceed external benchmarks, because client end-users (whether patients, infants, or wellness customers) place high trust in reliability and safety.
Physician nutrition companies prefer a DHA-EE source that delivers consistent dose, resists oxidation during blending, and stands up to aggressive labeling standards. We have supported customers formulating evidence-backed cognitive support blends, pediatric nutrition supplements, and cardiovascular wellness products. In each of these spaces, downstream stability and accurate labeling requirements mean the raw ingredient must track completely from input to final use, with little tolerance for deviation.
Functional food producers demand not just nutritional potency but ease of blending with other lipids, flavorings, or stabilizers. Our years spent observing batches during large-scale bar or beverage production revealed that inferior DHA-EE sources often disrupt texture, cause unpredictable syneresis, or introduce unexpected aromas. Suppliers quick to cut corners or obscure origins often fail to predict the end use ramifications—a lesson taught by past recalls and reformulations that could have been avoided by transparent sourcing and consistent chemistry.
Academic and clinical researchers use our DHA-EE for in vitro studies and clinical trials. Reproducibility counts more than marketing claims. Some grant agencies now mandate detailed analytical disclosure from ingredient suppliers—a shift our traceability and in-house testing already supported before these standards entered common practice.
Solving real-world problems takes more than producing an ingredient—it demands living with it, field testing, retesting, and handling unexpected phone calls from customers experiencing shipping delays, temperature excursions, or analytical surprises. Years of managing sensitive shipments taught us how to communicate shelf stability, test samples across a range of environmental conditions, and suggest storage routines that maintain quality through the entire distribution chain. Product stewardship follows from this commitment.
We have replaced competitor products at customer request after downstream failures: softgel leakage, bar separation, or batch upsets traced directly to source impurity profiles or overlooked storage recommendations. Building useful technical guides and offering batch-specific insight come naturally after shouldering the responsibility that comes with being the actual manufacturer, not a distant trader or unaccountable broker.
Partnering directly with formulators, food scientists, and research teams sheds new light on product requirements. The value of a ready-to-use DHA-EE rises with each successful product launch or published study showing real world benefit. Production data moves from manufacturing logs into case studies, technical manuals, and regulatory submissions—evidence that the right approach at the manufacturing level supports outcomes beyond the factory gate.
Chemistry changes as new analytical tools and process innovations emerge. A culture of process review, staff training, and open troubleshooting delivers real progress in both product and support. We commit lab resources to investigate outlier samples, historical performance, and root causes for even minor deviations. Continuous improvement isn’t a slogan for us—it’s visible in our steadily rising average purity level, ever-lower impurity counts, and tighter compliance with demanding customer specs.
Long-term feedback cycles close the loop between plant floor workers, QC staff, commercial teams, and end users. Solutions for unexpected odor issues, repeatability tests, or storage instability often emerge after months of collaborative problem solving, cross-sample tests, and data sharing across teams. Good chemistry follows from open dialogue and hands-on attention. Factory visits, joint sampling, and technical exchanges with key users earn a transparency dividend—customers call us with new problems because they know we work solutions to closure.
Ethyl Cis-4,7,10,13,16,19-Docosahexaenoate, made to uncompromising standards, fits a unique role in today’s marketplace. Nutritional advancement, functional food innovation, and clinical research all benefit from consistent sources that deliver on promises—the value of quality emerges fully only after seeing how careless production, incomplete batch documentation, or unwillingness to support after-sales issues lead to costly setbacks. We own both the learning curve and the outcome, knowing each container shipped represents not just a commodity, but a cumulative record of every lesson learned, spec met, and customer partnership honored. This is what being a true manufacturer means—no shortcuts, only experience, rigor, and responsibility carried forward into every batch made.